Celcuity, Inc. (CELC)
92.20
+1.41
(+1.55%)
USD |
NASDAQ |
Aug 25, 16:00
92.20
0.00 (0.00%)
After-Hours: 19:59
Celcuity Max Drawdown (5Y) : 82.70% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 82.70% |
| June 30, 2026 | 82.70% |
| May 31, 2026 | 82.70% |
| April 30, 2026 | 82.70% |
| March 31, 2026 | 82.70% |
| February 28, 2026 | 82.70% |
| January 31, 2026 | 82.70% |
| December 31, 2025 | 82.70% |
| November 30, 2025 | 82.70% |
| October 31, 2025 | 82.70% |
| September 30, 2025 | 83.33% |
| August 31, 2025 | 83.43% |
| July 31, 2025 | 83.43% |
| June 30, 2025 | 83.43% |
| May 31, 2025 | 83.43% |
| April 30, 2025 | 83.75% |
| March 31, 2025 | 85.64% |
| February 28, 2025 | 85.64% |
| January 31, 2025 | 85.64% |
| December 31, 2024 | 85.64% |
| November 30, 2024 | 85.64% |
| October 31, 2024 | 85.64% |
| September 30, 2024 | 85.64% |
| August 31, 2024 | 85.64% |
| July 31, 2024 | 85.64% |
| Date | Value |
|---|---|
| June 30, 2024 | 85.64% |
| May 31, 2024 | 85.64% |
| April 30, 2024 | 85.64% |
| March 31, 2024 | 85.64% |
| February 29, 2024 | 85.64% |
| January 31, 2024 | 85.64% |
| December 31, 2023 | 85.64% |
| November 30, 2023 | 85.64% |
| October 31, 2023 | 85.64% |
| September 30, 2023 | 85.64% |
| August 31, 2023 | 85.64% |
| July 31, 2023 | 85.64% |
| June 30, 2023 | 85.64% |
| May 31, 2023 | 85.64% |
| April 30, 2023 | 85.64% |
| March 31, 2023 | 85.64% |
| February 28, 2023 | 85.64% |
| January 31, 2023 | 85.64% |
| December 31, 2022 | 85.64% |
| November 30, 2022 | 85.64% |
| October 31, 2022 | 85.64% |
| September 30, 2022 | 85.64% |
| August 31, 2022 | 85.64% |
| July 31, 2022 | 85.64% |
| June 30, 2022 | 85.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Cogent Biosciences, Inc. | 94.16% |
| Replimune Group, Inc. | 95.70% |
| Erasca, Inc. | 95.64% |
| Apogee Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 28.85 |
| Beta (5Y) | 0.2055 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 129.1% |
| Historical Sharpe Ratio (5Y) | 0.2382 |
| Historical Sortino (5Y) | 1.035 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.34% |